SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept (VERO) is trending following news of Madryn Asset Management acquiring a significant 91% stake, prompting discussions about potential privatization or delisting to reduce costs. This has ignited debate among traders, with bulls anticipating a massive short squeeze due to the extremely low public float, while skeptics warn of a pump-and-dump scenario. The community is actively discussing the implications of this majority ownership on the stock's future, balancing hopes for a continued rally against concerns for potential dilution or a low buyout.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently trending due to intense anticipation surrounding its upcoming Cohort 4 data readout for Soquelitinib in atopic dermatitis, expected in January. The community is highly optimistic about the novel oral therapy's potential and its broader implications for autoimmune diseases, with much discussion centering on whether the recent cancellation of a major industry conference presentation hints at a significant partnership or buyout alongside positive results.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is experiencing significant momentum following Saudi FDA approval for its ANKTIVA drug in both lung and bladder cancer, alongside a reported 700% surge in full-year revenue. The community is buzzing with anticipation of a potential short squeeze and substantial long-term upside, while actively discussing the implications of this international recognition for future U.S. approvals. Many are calling for the US FDA to accelerate its review, highlighting the drug's broad applicability across various cancer types and potential for new financial partnerships.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is actively trending amid intense political discourse surrounding recent developments, including the narrative around a perceived Nobel Peace Prize for the former President and his controversial stance on acquiring Greenland with tariff threats. Community discussions are highly polarized, debating recent ICE actions in Minneapolis, alleged financial improprieties related to the company's merger, and ongoing legal battles. The stock remains a focal point for broader political commentary rather than purely financial analysis, reflecting deep divisions.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is trending due to its significant strategic pivot, recently solidified by a long-term data center lease agreement with AMD. The community is buzzing with excitement, viewing this deal as a major validation of Riot's extensive power infrastructure and its potential to become a dominant player in AI and high-performance computing. This move is also fueling discussions about Riot's potential to secure further large-scale deals beyond traditional Bitcoin mining, with many expecting continued upside as the company leverages its substantial power capacity.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is a top trending stock as investors eagerly await its "Eagle Line inauguration event" and upcoming earnings in February, anticipating crucial updates on OEM partnerships and production scaling. Despite widespread long-term bullish conviction in its disruptive solid-state battery technology, the community is navigating recent price volatility and debating new, unverified competitive claims.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is actively discussed following recent developments like the 'Mission 70' tokenomics whitepaper and the launch of 'Chain Fusion' for native interoperability across major blockchains. Supporters view ICP as a 'criminally undervalued' leader in decentralized AI and cloud computing, with strong potential for future adoption. However, a segment of the community remains skeptical, pointing to its past price volatility and questioning its ability to sustain gains.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is experiencing intense debate as it trades near multi-year lows, fueling community discussion over its future. Many investors are concerned about potential competition from major tech players and question management's ability to halt the stock's decline, labeling it a "falling knife." Conversely, a bullish contingent views the stock as deeply "oversold" given its strong financial health and ongoing analyst support, anticipating a rebound in the ad tech sector.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending as investor attention shifts to its strategic transformation into a major AI/HPC data center provider, securing long-term contracts with prominent hyperscalers. The community is buzzing about its strong pipeline of potential new deals and solid financial position, anticipating significant growth beyond its Bitcoin mining roots despite short-term market volatility.

Memecoin on Injective taken over by the community.

Nonja

NONJA is trending as a high-conviction meme coin directly linked to the Injective (INJ) ecosystem, which its dedicated community anticipates will see explosive growth due to strong fundamentals and an undervalued market position. Hailed as the premier meme on Injective, $NONJA is garnering significant attention for its high burned liquidity, resilient community, and potential to deliver leveraged returns as the underlying chain gains momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SG Americas Securities LLC Takes Position in Nuvalent, Inc. $NUVL

SG Americas Securities LLC purchased a new position in shares of Nuvalent, Inc. (NASDAQ:NUVL - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the...

Nuvalent (NASDAQ:NUVL) Stock Price Up 7.3% - Here's Why

Nuvalent (NASDAQ:NUVL) Trading Up 7.3% - Should You Buy...

Nuvalent (NASDAQ:NUVL) Stock Price Down 6.7% - What's Next?

Nuvalent (NASDAQ:NUVL) Stock Price Down 6.7% - Here's What Happened...

Nuvalent Announces OnTarget 2026 Operating Plan Progress and Outlines Key Anticipated 2026 Milestones

Nuvalent Announces OnTarget 2026 Operating Plan Progress and Outlines Key Anticipated 2026 Milestones Nuvalent Announces OnTarget 2026 Operating Plan Progress and Outlines Key Anticipated 2026...

Nuvalent, Inc. (NASDAQ:NUVL) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Nuvalent, Inc. (NASDAQ:NUVL - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the sixteen analysts that are currently covering the firm, Marketbeat...

3 Biotech Stocks With Major 2026 Catalysts

Biotech's 2025 rebound sets the stage for Denali Therapeutics and two peers, with key FDA decisions and pipeline catalysts lined up for 2026.

Nuvalent, Inc. $NUVL Shares Bought by Voya Investment Management LLC

Voya Investment Management LLC lifted its stake in shares of Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 9.4% during the third quarter, according to the company in its most recent disclosure with...

Nuvalent to Present at the 44th Annual J.P. Morgan Healthcare Conference

Nuvalent to Present at the 44th Annual J.P. Morgan Healthcare Conference Nuvalent to Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire CAMBRIDGE, Mass., Dec. 22, 2025...

JPMorgan Chase & Co. Lowers Nuvalent (NASDAQ:NUVL) Price Target to $145.00

JPMorgan Chase & Co. decreased their target price on shares of Nuvalent from $147.00 to $145.00 and set an "overweight" rating on the stock in a research note on Friday...

Natixis Makes New $1.75 Million Investment in Nuvalent, Inc. $NUVL

Natixis purchased a new position in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange...

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.

Current Price	$104.26
Prev Close	$106.16
Open	$106.43
Dividend Yield	0.00%
50-Day Moving Average	$103.20
Beta	1.16
Avg. Volume	508,038.14
PE Ratio	-19.61

52-Week High	$112.88
52-Week Low	$55.54
Market Capitalization	$7.72B
EPS (Annual)	-$3.93
Price to Book	8.91
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

NUVL
Nuvalent Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NUVL News

NUVLNuvalent Inc - Ordinary Shares - Class A